Inhibition of phosphatidylinositol 4,5-bisphosphate-stimulated phospholipase D2 activity by Ser/Thr phosphorylation1This work was supported in part by research grants from the Ministry of Education, Science, Sports and Culture, Japan.1  by Watanabe, Hiroshi & Kanaho, Yasunori
Rapid report
Inhibition of phosphatidylinositol 4,5-bisphosphate-stimulated
phospholipase D2 activity by Ser/Thr phosphorylation1
Hiroshi Watanabe, Yasunori Kanaho *
Department of Biological Information, Tokyo Institute of Technology, Nagatsuta, Midori-ku, Yokohama 226-8501, Japan
Received 17 November 1999; accepted 7 December 1999
Abstract
Treatment of HeLa cells overexpressing PLD2 with the Ser/Thr-specific protein phosphatase inhibitor, okadaic acid,
augmented spontaneous phosphorylation of PLD2 with concomitant inhibition of phosphatidylinositol 4,5-bisphosphate
(PIP2)-stimulated PLD2 activity. Dephosphorylation of the immunoprecipitated, spontaneously phosphorylated PLD2 in
COS-7 cells by catalytic subunit of protein phosphatase 1Q1 resulted in the stimulation of the PLD2 catalytic activity. These
observations suggest that Ser/Thr phosphorylation regulates PLD2 activity. ß 2000 Elsevier Science B.V. All rights
reserved.
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In a wide variety of types of mammalian cells,
phospholipase D (PLD) is activated to produce cho-
line and phosphatidic acid from phosphatidylcholine
in response to a large number of extracellular signals
through G protein-coupled and tyrosine kinase re-
ceptors, being involved in various cell functions
such as secretion, mitogenesis, vesicular tra⁄c, and
cytoskeletal reorganization [1^5]. Two mammalian
PLD isozymes, PLD1 and PLD2, have so far been
cloned from human [6,7], rat [8,9], and mouse
[10,11]. PLD1, which includes two splice variant
forms, is activated by K and L isozymes of protein
kinase C and small G proteins, ADP-ribosylation
factor and members of Rho family GTPases, in the
presence of phosphatidylinositol 4,5-bisphosphate
(PIP2) [12]. On the other hand, PLD2 exhibits high
basal activity in the presence of PIP2, and does not
further respond to the PLD1 activators [11]. Because
PLD2 has high basal activity in vitro, it has been
assumed that in vivo its activity is normally sup-
pressed by its inhibitor(s) [11]. Although K and L
synucleins have been found to inhibit PIP2-stimu-
lated PLD2 activity in vitro [11,13], it remains to
be clari¢ed whether they function as PLD2 inhibitors
in vivo. Recently, it has been reported that PLD2,
which was co-expressed with epidermal growth factor
(EGF) receptor in human embryonic kidney ¢bro-
blasts, is phosphorylated on Tyr-11 and activated
upon stimulation of cells by EGF [14]. Substitution
of Phe for this residue, however, did not a¡ect the
magnitude of the EGF-stimulated PLD2 activation.
These observations suggest that the EGF-induced ty-
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rosine phosphorylation of PLD2 is not essential for
the regulation of the enzyme activity. In the present
study, we have addressed another possibility that
PLD2 activity is regulated by its Ser/Thr phosphor-
ylation.
To overexpress FLAG epitope-tagged mouse
PLD2 (FLAG-PLD2) in mammalian cells, cDNA
of PLD2 was ampli¢ed from total RNA prepared
from mouse brain by RT-PCR using a set of primers
containing EcoRI site, and inserted into pTB701-
FLAG vector. HeLa cells or COS-7 cells were trans-
fected with 50 Wg of this plasmid by electroporation,
and cultured at 37‡C for 40 h in the presence of 5%
fetal calf serum (FCS).
Fig. 1 shows e¡ects of okadaic acid (OA, Calbio-
chem), the inhibitor of Ser/Thr-speci¢c protein phos-
phatase 1 and 2A, on phosphorylation and PIP2-
stimulated activity of the transiently expressed
FLAG-PLD2 in HeLa cells. When HeLa cells were
metabolically labeled with [32P]Pi in the presence of
5% FCS, overexpressed PLD2 was found to be spon-
taneously [32P]-phosphorylated. OA treatment of
cells during metabolic labeling evidently increased
the level of phosphorylation, indicating that PLD2
is a substrate for Ser/Thr protein kinase(s). Interest-
ingly, the immunoprecipitated PLD2 activity, which
was determined in the presence of PIP2, was signi¢-
cantly decreased by OA treatment. These results, tak-
en together, suggest that Ser/Thr phosphorylation of
PLD2 suppresses the PIP2-stimulated PLD2 activity.
Since spontaneous phosphorylation of overex-
pressed PLD2 in COS-7 cells was much greater
than that in HeLa cells (data not shown), FLAG-
PLD2 was overexpressed in COS-7 cells in the fol-
lowing experiments. When COS-7 cells overexpress-
ing FLAG-PLD2 were treated for the indicated times
with 100 WM of pervanadate, the phosphotyrosine-
speci¢c phosphatase inhibitor, mobility of PLD2 on
SDS-PAGE shifted in a time-dependent manner (Fig.
2A, top panel). This shift was due to the Tyr phos-
Fig. 1. Stimulation by okadaic acid of phosphorylation of
PLD2 in HeLa cells and consequent inhibition of PIP2-stimu-
lated PLD2 activity. HeLa cells, in which FLAG-PLD2 was
transiently expressed, were labeled with [32P]Pi (100 WCi/ml) at
37‡C for 3 h. For the last 1 h of labeling, cells were incubated
without or with 250 nM of OA. After cells were lysed in a
bu¡er containing 1% Nonidet P-40, solubilized FLAG-PLD2
was immunoprecipitated with the anti-FLAG M2 antibody resin
(Sigma). [32P]-phosphorylation of the immunoprecipitated
FLAG-PLD2 was analyzed by Fuji BAS-2000 Bioimaging Ana-
lyzer after FLAG-PLD2 was separated by SDS-PAGE. The im-
munoprecipitated PLD2 activity was assayed in the presence of
12 WM of PIP2 by determining [3H]choline released from the
substrate [choline-methyl-3H]dipalmitoylphosphatidylcholine as
described previously [15]. Results shown are the mean þ S.D. of
¢ve independent experiments with similar results. *, signi¢cantly
di¡erent from the corresponding control as assessed by Stu-
dent’s t-test (P6 0.05).
Fig. 2. Tyrosine phosphorylation of PLD2 overexpressed in
COS-7 cells does not a¡ect PIP2-stimulated PLD2 activity.
COS-7 cells, in which FLAG-PLD2 was overexpressed, were
treated at 37‡C with 100 WM of pervanadate for the indicated
times (A) or with the indicated concentrations of pervanadate
for 1 h (B), then FLAG-PLD2 was immunoprecipitated with
the anti-FLAG M2 antibody resin as described in Fig. 1. The
immunoprecipitated PLD2 (top panels) and its tyrosine phos-
phorylation (middle panels) were analyzed by Western blotting
with the anti-FLAG M2 antibody (FLAG-Ab) and PY-20, re-
spectively. PIP2-stimulated PLD2 activity in the immunoprecipi-
tant (bottom panels) was also determined as described in Fig.
1. The error represents the di¡erences of duplicate determina-
tions. The results shown are from a single experiment represen-
tative of three with similar results.
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phorylation of PLD2, as detected by the anti-phos-
photyrosine antibody PY-20 (Fig. 2A, middle panel).
The Tyr phosphorylation of PLD2 was also stimu-
lated in a pervanadate concentration-dependent fash-
ion (Fig. 2B, top and middle panels). However, per-
vanadate was without e¡ect on the PLD2 activity
determined in the presence of PIP2 (Fig. 2A and B,
bottom panels), demonstrating that Tyr phosphory-
lation does not modulate the PIP2-stimulated PLD2
activity. These results are consistent with the obser-
vation by Slaaby et al. that PLD2 is a substrate for
tyrosine protein kinase(s), but the Tyr phosphoryla-
tion is not essential for PLD2 activity [14].
To con¢rm the inhibition of PIP2-stimulated
PLD2 activity by Ser/Thr phosphorylation, PLD2,
which was spontaneously [32P]-phosphorylated in
and a⁄nity puri¢ed with the anti-FLAG antibody
resin from COS-7 cells, was treated with the catalytic
subunit of human protein phosphatase 1Q1 (PP1Q1c)
(Calbiochem), and the levels of phosphorylation and
of PIP2-stimulated PLD2 activity were compared
(Fig. 3). When spontaneously [32P]-phosphorylated
PLD2 in COS-7 cells was treated with 1.4 WM of
PP1Q1c at 25‡C for 1 h, phosphorylation level was
signi¢cantly decreased (Fig. 3A). With increasing
concentrations of PP1Q1c, both dephosphorylation
of PLD2 and PIP2-stimulated PLD2 activity were
increased with good correlation (Fig. 3B). Thus,
Ser/Thr phosphorylation of PLD2 suppressed the
PIP2-dependent PLD2 activity.
The mechanism by which Ser/Thr phosphorylation
suppressed the PIP2-stimulated PLD2 activity can be
explained by either inhibition of catalytic activity of
PLD2 or the decrease in the a⁄nity of PLD2 for
PIP2. To analyze which mechanism is more likely,
concentration dependence of PIP2 in the activation
of the phosphorylated and dephosphorylated PLD2
was examined (Fig. 4). Both phosphorylated and de-
phosphorylated PLD2s were activated in a PIP2 con-
centration-dependent manner with almost the same
EC50 value (about 2.5 WM PIP2), leaching a plateau
at about 12 WM of PIP2. However, the maximal stim-
ulation by PIP2 of the dephosphorylated PLD2 was
Fig. 4. Mode of inhibition of PIP2-stimulated PLD2 activation
by Ser/Thr phosphorylation. Spontaneously [32P]-phosphory-
lated PLD2 in COS-7 cells was immunoprecipitated and treated
without (open circles) or with 1.4 WM PP1Q1c (closed circles),
as described in Fig. 3. The activities of phosporylated and de-
phosphorylated PLD2 were determined in the presence of the
indicated concentrations of PIP2. The error represents the dif-
ferences of duplicate determinations. The results shown are
from a single experiment representative of three with similar re-
sults.
Fig. 3. Inhibition by Ser/Thr phosphorylation of PIP2-stimu-
lated PLD2 activity. COS-7 cells overexpressing FLAG-PLD2
were labeled with [32P]Pi (30 WCi/ml) at 37‡C for 24 h in the
presence of 5% FCS, then FLAG-PLD2 was immunoprecipi-
tated with the anti-FLAG antibody resin. The a⁄nity-puri¢ed
FLAG-PLD2 was then incubated at 25‡C for 1 h without or
with 1.4 WM (A) or the indicated concentrations of PP1Q1c (B).
The level of phosphorylation of PLD2 was analyzed by autora-
diography (A) or Fuji BAS-2000 Bioimaging Analyzer (B,
closed circles) after SDS-PAGE of the immunoprecipitated
PLD2. The immunoprecipitated PLD2 activity in the presence
of PIP2 (B, open circles) was determined as described in Fig. 1.
The error represents the di¡erences of duplicate determinations.
The results shown are from a single experiment representative
of three with similar results.
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higher than that of the phosphorylated PLD2. These
results demonstrate that Ser/Thr phosphorylation in-
hibits the catalytic activity of PLD2 without interfer-
ence with the a⁄nity for PIP2.
In conclusion, PLD2 can be phosphorylated on its
Ser/Thr residue(s), and the Ser/Thr phosphorylation
results in the inhibition of the catalytic activity of
PLD2. When HeLa cells co-overexpressing PLD2
and EGF receptors were treated with OA, EGF-
stimulated PLD activity was evidently inhibited
(data not shown). These observations are consistent
with the idea that agonist-stimulated PLD2 activa-
tion is regulated, at least in part, by Ser/Thr phos-
phorylation.
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